EUVIMEDEUVIMED entdecken
Crossref

HLA‐A*11:01 and HLA‐C*04:01 are associated with severe COVID ‐19

Patricia Castro-Santos, Augusto Rojas-Martinez, José A Riancho, Pablo Lapunzina, Carlos Flores, Ángel Carracedo, Roberto Díaz-Peña iD, Scourge Cohort Group

HLA · 2023-12 · 102 (6) · 731-739

DOI: 10.1111/tan.15160 ↗

Kurz gefasst

Fachartikel in der Zeitschrift HLA, 2023-08. Verfasst von Patricia Castro-Santos und 7 weiteren Autor:innen. Beteiligte Einrichtung: Fundación Pública Galega de Medicina Xenómica (SERGAS), Centro Nacional de Genotipado, Health Research Institute of Santiago de Compostela (IDIS), Sa…. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Instituto de Salud Carlos III, European Regional Development Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We analyzed the association between HLA polymorphisms and susceptibility to SARS‐CoV‐2 infection and disease severity. Genotyping data from a total of 9373 COVID‐19‐positive cases from the Spanish Coalition to Unlock Research on Host Genetics on COVID‐19 (SCOURGE) consortium and 5943 population controls were included in the study. We found an association of the alleles HLA‐B*14:02 and HLA‐C*08:02 with a lower risk to COVID‐19 infection ( p = 0.006, OR = 0.84, 95% CI = [0.75–0.95], p = 0.024, OR = 0.86, 95% CI = [0.78–0.95], respectively). We also found the alleles HLA‐A*11:01 and HLA‐C*04:01 associated with disease severity ( p = 0.033, OR = 1.16, 95% CI = [1.04–1.31], p = 0.045, OR = 1.14, 95% CI = [1.05–1.25], respectively). These results suggest that an effective presentation of viral peptides by HLA class I alleles involve a faster infection clearance, decreasing the susceptibility and severity of COVID‐19.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19HumansHLA-C AntigensSARS-CoV-2Gene FrequencyAllelesHLA-A Antigens

Stichwörter der Autor:innen

COVID-19HLA evolutionary divergenceHLA-A*11:01HLA-C*04:01SARS-CoV-2immunogenetics

Substanzen

HLA-C AntigensHLA-A Antigens

Autor:innen und Institutionen

  • Fundación Pública Galega de Medicina Xenómica (SERGAS), Centro Nacional de Genotipado, Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain.
  • Faculty of Health Sciences, Universidad Autónoma de Chile, Talca, Chile.
  • Tecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Monterrey, Mexico.
  • IDIVAL, Cantabria, Spain.
  • Universidad de Cantabria, Cantabria, Spain.
  • Hospital U M Valdecilla, Cantabria, Spain.

ORCID-Profile: Roberto Díaz-Peña

Förderung

  • Instituto de Salud Carlos III
  • European Regional Development Fund

Zitieren

APA

Castro-Santos, P., Rojas-Martinez, A., Riancho, J. A., Lapunzina, P., Flores, C., Carracedo, Á., Díaz-Peña, R., & Scourge Cohort Group (2023). HLA‐A*11:01 and HLA‐C*04:01 are associated with severe COVID ‐19. HLA, 102(6), 731-739. https://doi.org/10.1111/tan.15160

Vancouver

Castro-Santos P, Rojas-Martinez A, Riancho JA, Lapunzina P, Flores C, Carracedo Á, et al. HLA‐A*11:01 and HLA‐C*04:01 are associated with severe COVID ‐19. HLA. 2023;102(6):731-739. doi:10.1111/tan.15160

BibTeX
@article{CastroSantos2023,
  author = {Castro-Santos, Patricia and Rojas-Martinez, Augusto and Riancho, José A and Lapunzina, Pablo and Flores, Carlos and Carracedo, Ángel and Díaz-Peña, Roberto and Scourge Cohort Group, Scourge Cohort Group},
  title = {HLA‐A*11:01 and HLA‐C*04:01 are associated with severe COVID ‐19},
  journal = {HLA},
  year = {2023},
  volume = {102},
  number = {6},
  pages = {731--739},
  doi = {10.1111/tan.15160}
}
Kostenlos starten →